Document Classification

Section Type: METHODS

Text: Outcome measures were plasminogen activator inhibitor type 1 (PAI-1), homocysteine, fibrinogen, fasting glucose, blood pressure, high-density lipoprotein cholesterol, triglycerides, low-density lipoprotein cholesterol, and '' lipid metabolic disorder '' (LMD) (defined as systolic blood pressure > / = 140 mm Hg or diastolic blood pressure > / = 90 mm Hg) ; fasting glucose > / = 126 mg/dL (> / = 7. 0 mmol/L) or the use of diabetes medications ; body mass index (calculated as weight in kilograms divided by the square of height in meters) > / = 30 ; triglycerides > / = 250 mg/dL (> / = 2. 8 mmol/L), high-density lipoprotein cholesterol < 40 mg/dL (< 1. 0 mmol/L) in men and < 50 mg/dL (< 1. 3 mmol/L) in women ; and low-density lipoprotein cholesterol level > / = 130 mg/dL (> / = 3. 4 mmol/L).